SCHEMBL214653

SCHEMBL214653

O=C=NCCCCCCCl

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
TSHR P16473 2/20 0.33
NAAA Q02083 1/20 0.31
MIF P14174 1/20 0.31
GSK3B P49841 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11591058 1.00 ALDH1A1 (0.33) ALDH1A1TSHRNAAAMIFGSK3B
SCHEMBL9191068 1.00 ALDH1A1 (0.33) ALDH1A1TSHRNAAAMIFGSK3B
SCHEMBL9190588 1.00 ALDH1A1 (0.33) ALDH1A1TSHRNAAAMIFGSK3B
SCHEMBL9191211 1.00
SCHEMBL1918828 0.97
Methylene Chloride SCHEMBL28181786 0.89 NAAA (0.33) NAAAMIFGSK3B
SCHEMBL243594 0.89
SCHEMBL27700886 0.89 TSHR (0.54) ALDH1A1TSHRNAAATDP1
SCHEMBL8742957 0.86 MIF (0.38) ALDH1A1NAAAMIFGSK3B
SCHEMBL3238884 0.86 MIF (0.38) ALDH1A1NAAAMIFGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BASF SE (DE) 2025-12-30 US claimed
CN-117550982-A Treatment method of hexamethylene diisocyanate light component and preparation method of hexamethylene diisocyanate 宁夏瑞泰科技股份有限公司 2024-02-13 CN claimed
US-20230348657-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-11-02 US claimed
EP-4185626-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-05-31 EP claimed
CN-116137864-A Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component 巴斯夫欧洲公司 2023-05-19 CN claimed
CN-112996835-B Method for producing thermoplastic polyoxazolidone polymers 科思创知识产权两合公司 2022-12-13 CN claimed
US-11427671-B2 Method for the production of thermoplastic polyoxazolidinone polymers COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2022-08-30 US claimed
EP-3873961-B1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-08-17 EP claimed
US-11370874-B2 Method for the production of thermoplastic polyoxazolidone polymers COVESTRO DEUTSCHLAND AG (DE) 2022-06-28 US claimed
EP-3681924-B1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-05-18 EP claimed
EP-3456754-A1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS Covestro Deutschland AG (DE) 2019-03-20 EP claimed
EP-3456753-A1 METHOD FOR THE PRODUCTION OF THERMPLASTIC POLYOXAZOLIDINONE POLYMERS Covestro Deutschland AG (DE) 2019-03-20 EP claimed
WO-2018141743-A1 METHOD FOR THE PRODUCTION OF POLYOXAZOLIDINONE POLYMER COMPOUNDS COVESTRO DEUTSCHLAND AG (DE) 2018-08-09 WO claimed
EP-3357949-A1 METHOD FOR THE PRODUCTION OF POLYOXAZOLIDINONE POLYMER COMPOUNDS Covestro Deutschland AG (DE) 2018-08-08 EP claimed
US-10040808-B2 Silane-modified formamides COVESTRO DEUTSCHLAND AG (DE) 2018-08-07 US claimed
WO-2018033562-A1 PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS COVESTRO DEUTSCHLAND AG (DE) 2018-02-22 WO claimed
US-20180022871-A1 PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY COVESTRO DEUTSCHLAND AG (DE) 2018-01-25 US claimed
EP-3256508-A1 PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY Covestro Deutschland AG (DE) 2017-12-20 EP claimed
WO-2016128380-A1 PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY COVESTRO DEUTSCHLAND AG (DE) 2016-08-18 WO claimed
US-4918148-A IMPROVED FLOWABILITY, MOLD RELEASE AND-OR NOTCHED IMPACT STRENGTH BAYER AKTIENGESELLSCHAFT (DE) 1990-04-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509547-B2 Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component BMP1, BMP4, PBRM1 ALDH1A1 1995/4885TSHR 4875/4885NAAA 3820/4885
US-10040808-B2 Silane-modified formamides PFAS, ITGA8, CAD ALDH1A1 979/4885TSHR 4875/4885NAAA 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.